Products | May 01, 2009

Attrius

Related Content

CVAUSA to Broaden Rollout of GE Healthcare's Flyrcado PET Radiotracer
News | PET Imaging
CVAUSA to Broaden Rollout of GE Healthcare's Flyrcado PET Radiotracer

Nov. 17, 2025 — GE HealthCare has announced that Cardiovascular Associates of America (CVAUSA) plans to broaden its ...

Home November 17, 2025
Home
New Clinical Guidelines Available for PET Imaging of Patients with Coronary Artery Disease
News | PET Imaging
New Clinical Guidelines Available for PET Imaging of Patients with Coronary Artery Disease

Sept. 18, 2025 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI), American Society of Nuclear Cardiology ...

Home September 22, 2025
Home
GE HealthCare, CDL Nuclear Technologies Group Enter Agreement to Distribute Flyrcado 
News | PET Imaging
GE HealthCare, CDL Nuclear Technologies Group Enter Agreement to Distribute Flyrcado 

Sept. 8, 2025 — GE HealthCare recently announced a Distribution and Services Agreement (DSA) with CardioNavix, a part of ...

Home September 08, 2025
Home
Abnormal Long COVID PET/MR Findings
News | PET Imaging
Abnormal Long COVID PET/MR Findings Linked to Future Cardiac, Pulmonary Diseases

July 21, 2025 — Long COVID patients with abnormal cardiopulmonary PET/MR findings may be more likely to develop heart ...

Home July 22, 2025
Home
News | PET Imaging
Patients Undergo First Doses of New Cardiac PET tracer

Feb. 25, 2025— GE HealthCare has delivered the first patient doses of Flyrcado (flurpiridaz F 18) injection, a unit dose ...

Home March 03, 2025
Home
Positron will install the Attrius in Q4 2024 in accordance with the facility’s timeline.
News | PET Imaging
Positron Corporation Announces Attrius PET System Sale

June 18, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Home June 18, 2024
Home
The CPIC will be a leading advocate for fair and transparent coverage and reimbursement policies that facilitate access to cardiac PET
News | PET Imaging
Positron Corporation Joins Cardiac PET Industry Coalition (CPIC)

June 14, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Home June 14, 2024
Home
Offering healthcare facilities with the option to either use a flexible daily-leased rubidium program or build a full time PET program will ultimately increase access for suspected CAD patients to state of the art imaging with cardiac PET.
News | PET Imaging
Jubilant Radiopharma and Cardiac Imaging, Inc. Announce Exclusive Partnership to Expand Access for Mobile Cardiac PET Offering

October 5, 2023 — Jubilant DraxImage Inc., a wholly-owned subsidiary of Jubilant Pharma Limited, has entered into an ...

Home October 05, 2023
Home
A team led by UTHealth Houston's K. Lance Gould, MD, (center) used PET imaging technology (shown above) to map coronary blood flow and its outcomes among heart disease patients. (Photo by UTHealth Houston)
News | PET Imaging
PET Technology More Effective Than Angiogram at Determining Need for Coronary Stents, Bypass Surgery

December 1, 2022 — A new method for determining whether patients with heart disease need coronary stents or bypass ...

Home December 01, 2022
Home
Phase III clinical trial of [18F]flurpiridaz PET diagnostic radiopharmaceutical meets co-primary endpoints for detecting Coronary Artery Disease (CAD)
News | PET Imaging
GE Healthcare and Lantheus Phase III Clinical Trial Finds [18F]flurpiridaz PET Radiotracer Could Improve Detection of Coronary Artery Disease

September 14, 2022 — GE Healthcare and Lantheus Holdings Inc have announced that the recent Phase III clinical trial of ...

Home September 14, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now